Atlassian Co-Founders Sell $4M in TEAM Stock in Coordinated Week-Long Dump
Both Scott Farquhar and Mike Cannon-Brookes sold thousands of Atlassian shares across Jan 23-28 in near-identical transaction patterns, totaling approximately $4M in combined dispositions.
Both Atlassian Co-Founders Dumped Nearly 30,000 Shares in a Single Week
Scott Farquhar and Mike Cannon-Brookes, the co-founders of Atlassian (TEAM), sold a combined ~29,400 shares worth approximately $3.95 million between January 23 and January 28, 2026, according to Form 4 filings with the SEC. The transactions were executed in near-identical lot sizes on the same dates — a pattern consistent with pre-arranged 10b5-1 trading plans.
Transaction Breakdown
Scott Farquhar — Co-CEO, Director, 10%+ Owner
Farquhar sold approximately 20,033 shares for a total of ~$2.67 million across three trading days:
| Date | Transactions | Shares Sold | Avg Price | Est. Value |
|---|---|---|---|---|
| Jan 28 | 5 | 7,665 | $135.40 | $1.04M |
| Jan 27 | 8 | 7,665 | $133.40 | $1.02M |
| Jan 23 | 2 | 4,703 | $130.40 | $0.61M |
After these sales, Farquhar retains approximately 329,595 shares across trust structures and direct holdings. His lifetime sell total now stands at $1.27 billion across 5,387 Form 4 transactions.
Mike Cannon-Brookes — CEO, Co-Founder, 10%+ Owner
Cannon-Brookes sold approximately 9,415 shares for ~$1.28 million over two days:
| Date | Transactions | Shares Sold | Avg Price | Est. Value |
|---|---|---|---|---|
| Jan 28 | 5 | 7,665 | $135.40 | $1.04M |
| Jan 27 | 5 | 1,750 | $134.50 | $0.24M |
Cannon-Brookes also retains approximately 329,595 shares post-sale. His career selling total: $1.26 billion across 5,379 transactions.
Farquhar vs Cannon-Brookes: Daily Shares Sold (Jan 2026)
The Pattern: Mirror-Image Lot Sizes
The most striking detail is the identical lot sizes on Jan 28. Both founders sold exactly 7,665 shares that day, broken into the same five transaction blocks: lots of 3,700, 445, 455, 281/280, and 2,784/2,785 shares at nearly identical weighted average prices. This level of precision is a textbook signature of coordinated Rule 10b5-1 trading plans — pre-scheduled sell programs filed in advance that remove discretionary timing from insider dispositions.
It also means the selling was not a reaction to any specific news event. These plans are typically established weeks or months before execution.
Context: What This Means for TEAM Holders
While $4 million sounds significant, it represents a tiny fraction of each founder’s holdings. At ~$135/share, Farquhar and Cannon-Brookes each still hold roughly $44.5 million in TEAM stock through their direct and trust positions alone — and that doesn’t account for additional beneficial ownership structures.
Both co-founders have been consistent sellers over the years, with lifetime totals exceeding $1.2 billion each. This week’s sales represent a continuation of a long-running liquidity program, not a sudden change in sentiment.
What to Watch
- Selling cadence: Both founders have been filing Form 4s weekly in January 2026. Watch for whether the pace continues or accelerates into February.
- Upcoming earnings: Atlassian’s next quarterly report will provide context on whether these sales preceded any material developments.
- 10b5-1 plan amendments: Any modification to the trading plans would be a more meaningful signal than the scheduled sales themselves.
Track insider activity for Scott Farquhar and Mike Cannon-Brookes on 13F Insight.
Related Research
Explore all researchVictory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Raymond James used Q4 2025 to keep broad ETF exposure high through VOO, AGG, SPY and IEFA while also adding to sector sleeves such as XLK and XLE. The next filing will show whether that balanced ETF-heavy structure remains the preferred setup.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Nuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Apr 17, 2026
Janus Henderson kept Nvidia and Microsoft on top in Q4 2025, but the more interesting signal was underneath: new exposure to Intuitive Surgical, Protagonist Therapeutics and other growth-healthcare names. The next filing will show whether that rotation keeps building.
Apr 17, 2026